405
Views
34
CrossRef citations to date
0
Altmetric
Reviews

Delivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriers

&
Pages 1583-1591 | Published online: 19 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar & Sarwar Beg. (2021) Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opinion on Drug Delivery 18:4, pages 489-513.
Read now
Jun Chen, Junhong Yao, Zhuyue Ma, Pei Peng, Shanshan Lu, Yudong Hu, Fei Xu, Yang Yang & Xixiong Yang. (2017) Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition. Journal of Liposome Research 27:1, pages 21-31.
Read now
Igor Slivac, David Guay, Mathias Mangion, Juliette Champeil & Bruno Gaillet. (2017) Non-viral nucleic acid delivery methods. Expert Opinion on Biological Therapy 17:1, pages 105-118.
Read now
Min Li, Weiyue Zhang, Birong Wang, Yang Gao, Zifang Song & Qi Chang Zheng. (2016) Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma. International Journal of Nanomedicine 11, pages 5645-5669.
Read now

Articles from other publishers (30)

Sonali Mohanty, Sikta Panda, U. Devadharshini & Subhankar Paul. (2023) Proteins and their functionalization for finding therapeutic avenues in cancer: Current status and future prospective. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:2, pages 188862.
Crossref
Tian Tian, Jian Ruan, Jia Zhang, Chun-Xia Zhao, Dong Chen & Jianzhen Shan. (2022) Nanocarrier-Based Tumor-Targeting Drug Delivery Systems for Hepatocellular Carcinoma Treatments: Enhanced Therapeutic Efficacy and Reduced Drug Toxicity. Journal of Biomedical Nanotechnology 18:3, pages 660-676.
Crossref
Jingyue Wang, Tong Zhou, Ying Liu, Shuangmin Chen & Zhenxiang Yu. (2022) Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors. Frontiers in Pharmacology 12.
Crossref
Qingming Bao, Tsogzolmaa Ganbold, Qiburi Qiburi, Mingming Bao, Shuqin Han & Huricha Baigude. (2021) AMP functionalized curdlan nanoparticles as a siRNA carrier: Synthesis, characterization and targeted delivery via adenosine A2B receptor. International Journal of Biological Macromolecules 193, pages 866-873.
Crossref
Sarah I. Bukhari, Syed Sarim Imam, Mohammad Zaki Ahmad, Parameswara Rao Vuddanda, Sultan Alshehri, Wael A. Mahdi & Javed Ahmad. (2021) Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges. Pharmaceutics 13:6, pages 840.
Crossref
Haroon Iqbal, Tao Yang, Ting Li, Miya Zhang, Hengte Ke, Dawei Ding, Yibin Deng & Huabing Chen. (2021) Serum protein-based nanoparticles for cancer diagnosis and treatment. Journal of Controlled Release 329, pages 997-1022.
Crossref
Miaomiao Kang, Zhijun Zhang, Nan Song, Meng Li, Panpan Sun, Xiaohui Chen, Dong Wang & Ben Zhong Tang. (2020) Aggregation‐enhanced theranostics: AIE sparkles in biomedical field. Aggregate 1:1, pages 80-106.
Crossref
Ruslan Kashapov, Gulnara Gaynanova, Dinar Gabdrakhmanov, Denis Kuznetsov, Rais Pavlov, Konstantin Petrov, Lucia Zakharova & Oleg Sinyashin. (2020) Self-Assembly of Amphiphilic Compounds as a Versatile Tool for Construction of Nanoscale Drug Carriers. International Journal of Molecular Sciences 21:18, pages 6961.
Crossref
Khan Muhammad, Jing Zhao, Ihsan Ullah, Jintang Guo, Xiang-kui Ren & Yakai Feng. (2020) Ligand targeting and peptide functionalized polymers as non-viral carriers for gene therapy. Biomaterials Science 8:1, pages 64-83.
Crossref
Roland Böttger, Griffin Pauli, Po-Han Chao, Nojoud AL Fayez, Lukas Hohenwarter & Shyh-Dar Li. (2020) Lipid-based nanoparticle technologies for liver targeting. Advanced Drug Delivery Reviews 154-155, pages 79-101.
Crossref
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu & Ram I. Mahato. (2019) Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 25, pages 66-87.
Crossref
Inmaculada Mora-Espí, Elena Ibáñez, Jorge Soriano, Carme Nogués, Thorarinn Gudjonsson & Leonardo Barrios. (2019) Cell Internalization in Fluidic Culture Conditions Is Improved When Microparticles Are Specifically Targeted to the Human Epidermal Growth Factor Receptor 2 (HER2). Pharmaceutics 11:4, pages 177.
Crossref
Zvi Fishelson & Michael Kirschfink. (2019) Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention. Frontiers in Immunology 10.
Crossref
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2019. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy 79 106 .
Ana del Pozo-Rodríguez, Alicia Rodríguez-Gascón, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Itziar Gómez-Aguado, Luigi S. Battaglia & María Ángeles Solinís. 2020. Current Applications of Pharmaceutical Biotechnology. Current Applications of Pharmaceutical Biotechnology 321 368 .
Fang Hu, Shidang Xu & Bin Liu. (2018) Photosensitizers with Aggregation-Induced Emission: Materials and Biomedical Applications. Advanced Materials 30:45, pages 1801350.
Crossref
Yi Gou, Dandan Miao, Min Zhou, Lijuan Wang, Hongyu Zhou & Gaoxing Su. (2018) Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics. Frontiers in Pharmacology 9.
Crossref
Yujie Zhang, Tao Sun & Chen Jiang. (2018) Biomacromolecules as carriers in drug delivery and tissue engineering. Acta Pharmaceutica Sinica B 8:1, pages 34-50.
Crossref
Nily Dan. 2018. Lipid Nanocarriers for Drug Targeting. Lipid Nanocarriers for Drug Targeting 529 562 .
Xingshu Li, Jihoon Kim, Juyoung Yoon & Xiaoyuan Chen. (2017) Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy. Advanced Materials 29:23, pages 1606857.
Crossref
Nily Dan. 2017. Nanostructures for Novel Therapy. Nanostructures for Novel Therapy 517 538 .
Jennifer Cheung, Takahiro Chino, Cynthia Co, Krystyna Konopka & Nejat Düzgünes. (2016) A nonviral vector with transfection activity comparable with adenoviral transduction. Therapeutic Delivery 7:11, pages 739-749.
Crossref
Yuan Sheng, Yiwen You & Yun Chen. (2016) Dual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancer. International Journal of Pharmaceutics 512:1, pages 1-13.
Crossref
Ruoyu Zhang, Guangxue Feng, Chong-Jing Zhang, Xiaolei Cai, Xiamin Cheng & Bin Liu. (2016) Real-Time Specific Light-Up Sensing of Transferrin Receptor: Image-Guided Photodynamic Ablation of Cancer Cells through Controlled Cytomembrane Disintegration. Analytical Chemistry 88:9, pages 4841-4848.
Crossref
Aritz Perez Ruiz de Garibay. (2016) Endocytosis in gene therapy with non-viral vectorsEndozytose in der Gentherapie mit nichtviralen Vektoren. Wiener Medizinische Wochenschrift 166:7-8, pages 227-235.
Crossref
Samuel T. Crowley & Kevin G. Rice. (2015) “Evolving nanoparticle gene delivery vectors for the liver: What has been learned in 30 years”. Journal of Controlled Release 219, pages 457-470.
Crossref
Susanta Sekhar Adhikari, Sujan Kumar Mondal & Rajkumar Banerjee. 2015. Heat Shock Protein-Based Therapies. Heat Shock Protein-Based Therapies 219 256 .
A. A. Rosenkranz, A. V. Ulasov, T. A. Slastnikova, Y. V. Khramtsov & A. S. Sobolev. (2014) Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment. Biochemistry (Moscow) 79:9, pages 928-946.
Crossref
Bingbing Wang, Chris V Galliford & Philip S Low. (2014) Guiding principles in the design of ligand-targeted nanomedicines. Nanomedicine 9:2, pages 313-330.
Crossref
K. K. Pohaku Mitchell, S. Sandoval, M. J. Cortes-Mateos, J. G. Alfaro, A. C. Kummel & W. C. Trogler. (2014) Self-assembled targeting of cancer cells by iron( iii )-doped, silica nanoparticles . J. Mater. Chem. B 2:45, pages 8017-8025.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.